Innovative Med Concepts LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Innovative Med Concepts LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11274
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovative Med Concepts LLC (Innovative Med Concepts) is a biotech company that develops novel treatments for the treatment of fibromyalgia and other related syndromes. The company’s pipeline products include NRP-1, a throat spray which is used to treat viral pharyngitis that provides relief to cancer patients undergoing head and neck radiation; and IMC-1, a novel proprietary fixed dose combination medication that is designed to treat chronic tissue-resident herpes simplex virus type 1. It also conducts research in various chronic ailments. The company collaborates with other organization for their pipeline development, licensing and commercialization. Innovative Med Concepts is headquartered in Tuscaloosa, Alabama, the US.

Innovative Med Concepts LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innovative Med Concepts LLC, Medical Devices Deals, 2012 to YTD 2018 9
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Innovative Med Raises USD1.03 Million in Venture Financing 11
Innovative Med Concepts to Raise USD6 Million in Financing Round 12
Innovative Med Concepts Raises US$3.1 Million In Venture Financing 13
Innovative Med Concepts LLC – Key Competitors 14
Innovative Med Concepts LLC – Key Employees 15
Innovative Med Concepts LLC – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Clinical Trials 17
Mar 07, 2017: Journal of Pain Research Publishes Results of PRID-201, a successful Phase 2 Trial using IMC-1 for the Treatment of Fibromyalgia 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Key Facts 2
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovative Med Concepts LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Innovative Med Concepts LLC, Medical Devices Deals, 2012 to YTD 2018 9
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Innovative Med Raises USD1.03 Million in Venture Financing 11
Innovative Med Concepts to Raise USD6 Million in Financing Round 12
Innovative Med Concepts Raises US$3.1 Million In Venture Financing 13
Innovative Med Concepts LLC, Key Competitors 14
Innovative Med Concepts LLC, Key Employees 15

List of Figures
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovative Med Concepts LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innovative Med Concepts LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Innovative Med Concepts LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Global Cardiovascular Innovation Center:医療機器:M&Aディール及び事業提携情報
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Clearside BioMedical Inc (CLSD):製薬・医療:M&Aディール及び事業提携情報
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Oil-Dri Corporation of America (ODC):企業の財務・戦略的SWOT分析
    Summary Oil-Dri Corporation of America (Oil-Dri) is a manufacturer and supplier of sorbent products. The company offers granular clay absorbents, universal absorbent products, oil only absorbents, haz mat, socks and boom, spill kits, sweeping compounds, and secondary containment products. Its univer …
  • Agios Pharmaceuticals Inc (AGIO):医療機器:M&Aディール及び事業提携情報
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Nippon Chemi-Con Corporation (6997):企業の財務・戦略的SWOT分析
    Nippon Chemi-Con Corporation (6997) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Multi Corporation:企業の戦略・SWOT・財務情報
    Multi Corporation - Strategy, SWOT and Corporate Finance Report Summary Multi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Jollibee Foods Corporation:企業の戦略・SWOT・財務情報
    Jollibee Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Jollibee Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • HeidelbergCement AG:戦略・SWOT・企業財務分析
    HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report Summary HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • McAfee, Inc.:企業の戦略的SWOT分析
    McAfee, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • Compass Diversified Holdings LLC:企業のM&A・事業提携・投資動向
    Compass Diversified Holdings LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compass Diversified Holdings LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • Realord Group Holdings Limited:企業の戦略・SWOT・財務情報
    Realord Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Realord Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AJ Lucas Group Ltd (AJL):石油・ガス:M&Aディール及び事業提携情報
    Summary AJ Lucas Group Ltd (Lucas) is an oil and gas drilling services provider. It provides engineering, construction and drilling services. The company offers directional drilling, pipe line construction and civil engineering, project management and other professional engineering services. It hold …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Millennium & Copthorne Hotels Plc:戦略・SWOT・企業財務分析
    Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Millennium & Copthorne Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Abengoa SA (ABG):電力:M&Aディール及び事業提携情報
    Summary Abengoa SA (Abengoa) is an applied engineering and equipment manufacturer. It employs novel technological solutions for sustainability in infrastructures, energy and water sectors. The company provides integrated project solutions. Abengoa’s solutions include engineering, and operation and m …
  • Bannerman Resources Ltd (BNNLF):企業の財務・戦略的SWOT分析
    Summary Bannerman Resources Ltd (Bannerman) is a mining and mineral exploration and development company. The company carries out the business of acquisition, exploration, and development of uranium properties. It holds interest in Etango Uranium Project located in Namibia near Rio Tinto’s Rossing ur …
  • HitGen LTD-製薬・医療分野:企業M&A・提携分析
    Summary HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company offers OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It provides bio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆